CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve the survival rates of pancreatic cancer patients by studying how the tumor microenvironment contributes to treatment resistance. It utilizes innovative models to explore the interactions between cancer cells and their surroundings, identifying potential new drug targets to enhance therapeut…
Pancreatic cancer is one of the most lethal human cancers with a five-year survival rate of less than 5%.
Late presentation and a high level of resistance to chemotherapeutic drugs are among the major reasons for this dismal prognosis.
The presence of the highest degree of desmoplasia among all solid tumours and the fact that chronic inflammatory pancreatic disease is associated with an increased risk for pancreatic cancer indicate, that the tumour microenvironment is of particular importance fo…
PHILIPPS UNIVERSITAET MARBURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Liverpool
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
Spain, Madrid
Type: Research institute
Activity type: Research Organisations
SME: No
Italy, Verona
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Greifswald
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
